Leap Therapeutics completed a $58.88 million private sale and launched its digital asset financial strategy.
According to HashiChain news, biotechnology company Leap Therapeutics has completed a $58.88 million private sale led by Winklevoss Capital to advance its digital asset financial strategy.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Leap Therapeutics completed a $58.88 million private sale and launched its digital asset financial strategy.
According to HashiChain news, biotechnology company Leap Therapeutics has completed a $58.88 million private sale led by Winklevoss Capital to advance its digital asset financial strategy.
#Cryptocurrency #Blockchain #WinklevossCapital #DigitalAssets #FinancialStrategy